The journal of sexual medicine
A rationale for PDE5 inhibitors as a cardiovascular risk mitigation strategy in postmenopausal women.
Abdullah Al-Mitwalli, Rachel S Rubin, Vikram Talaulikar, David Ralph, Pippa Sangster, John P Mulhall
Published: 202610.1093/jsxmed/qdaf397
No abstract available for this study.